ClinicalTrials.gov
ClinicalTrials.gov Menu

HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM (HeatShock)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00905060
Recruitment Status : Completed
First Posted : May 20, 2009
Last Update Posted : May 3, 2018
Sponsor:
Collaborator:
Agenus Inc.
Information provided by (Responsible Party):
Jennifer Clarke, University of California, San Francisco

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2014
  Actual Study Completion Date : April 2014
  Certification/Extension First Submitted : May 1, 2018